Inox Pharma Private Limited
About Inox Pharma Private Limited
Data last updated:
Inox Pharma Private Limited is a private limited company based in Guwahati, Assam, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 06 September 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U24232AS2005PTC007867. Its GSTIN is 18AABCI4463R1ZY (Assam). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.68 Lakh. It is led by directors Ajay Kumar Thapalia and Leela Chetry.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kumarpara F.A Road Fatasil Ambari, Guwahati, Assam, India – 781001.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.97 Lakh, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹8,404 (net margin 0.9%) and EBITDA of ₹15,522 (EBITDA margin 1.7%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Inox Pharma Private Limited's registered office is in Guwahati, Assam. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKumarpara F.A Road Fatasil Ambari, Guwahati, Assam, India – 781001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Inox Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Inox Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Inox Pharma Private Limited, buy the company report.
Financials of Inox Pharma Private Limited
FY 2025 filings availableInox Pharma Private Limited reported revenue of ₹8.97 Lakh (down 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 21% fall in the latest year. EBITDA rose 181% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15,522 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,404 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Inox Pharma Private Limited, buy the company report.
Board of directors of Inox Pharma Private Limited
Inox Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Kumar Thapalia | Director | 06 Sep 2005 | 21 Years 1 Months | Current |
| Leela Chetry | Director | 23 May 2017 | 9 Years 5 Months | Current |
Peer comparison
Inox Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Le Stone Infra India Private Limited | ₹8.98 Lakh (FY 2015) | Coimbatore, Tamil Nadu, India | ||||
| Berrybytes Private Limited | ₹8.98 Lakh (FY 2016) | 177.0% | Hyderabad, Telangana, India | |||
| Adiya Steelworks Private Limited | ₹8.98 Lakh (FY 2017) | Delhi, India | ||||
| Bombay Treat Private Limited | ₹8.98 Lakh (FY 2024) | 155.0% | Mumbai, Maharashtra, India | |||
| Sareen Pharma Private Limited | ₹8.97 Lakh (FY 2016) | -66.0% | Navi Mumbai, Maharashtra, India | |||
| Inox Pharma Private Limitedthis company | ₹8.97 Lakh (FY 2025) | ₹8,404 | 0.9% | -21.0% | Guwahati, Assam, India | |
| Sarva Vyapaar Private Limited | ₹8.97 Lakh (FY 2022) | -93.0% | Digha Ghat, Bihar, India | |||
| Agruna Industries Private Limited | ₹8.97 Lakh (FY 2025) | 71.0% | Bara Chauraha, Uttar Pradesh, India | |||
| Pharmestra Biotech Private Limited | ₹8.97 Lakh (FY 2024) | Delhi, India | ||||
| Romano Fashions Private Limited | ₹8.97 Lakh (FY 2025) | 71.0% | New Delhi, Delhi, India | |||
| Divitiae Pa Private Limited | ₹8.97 Lakh (FY 2025) | Gurgaon, Haryana, India |
To see the full peer comparison of Inox Pharma Private Limited, buy the company report.
Auditor
Inox Pharma Private Limited is audited by RAJESH SURANA & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJESH SURANA & CO | FY 2017 | 325658E |
Shareholding
The shareholding of Inox Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Inox Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Inox Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inox Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Inox Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AABCI4463R1ZY | Assam | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Inox Pharma Private Limited, buy the company report.
Recent activity
Inox Pharma Private Limited has 3 board changes on record since 2005: 2 appointments and 1 cessation. The latest: Mahendra Kumar Jain ceased to be Director on 06 Aug 2018.
Frequently asked questions
Inox Pharma is an active private limited company based in Guwahati, Assam, India. The company works in other wholesale, within the trading industry. It was incorporated on 06 September 2005 (21+ years old) and is registered under CIN U24232AS2005PTC007867.
Inox Pharma has 2 current directors:
- Ajay Kumar Thapalia - Director
- Leela Chetry - Director
The latest financial statements of Inox Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Inox Pharma is 18AABCI4463R1ZY, registered in Assam. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Inox Pharma is U24232AS2005PTC007867. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inox Pharma was incorporated on 06 September 2005, making it 21+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Inox Pharma by revenue are Le Stone Infra India Private Limited, Berrybytes Private Limited, Adiya Steelworks Private Limited, Bombay Treat Private Limited, Sareen Pharma Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Mahendra Kumar Jain ceased to be Director on 06 Aug 2018. Leela Chetry was appointed as Director on 23 May 2017. Ajay Kumar Thapalia was appointed as Director on 06 Sep 2005.
The registered office of Inox Pharma is at Kumarpara F.A Road Fatasil Ambari, Guwahati, Assam, India – 781001.
Inox Pharma operates in the trading industry, in the other wholesale segment.
The compliance status of Inox Pharma is compliant as of 10 July 2026. The company is actively filing with the Registrar of Companies.